Through comprehensive genomic characterization of genes driving NRF2-dependent cancer cell proliferation, we interrogated the functional interaction between NRF2 and CBP/p300 to uncover a role for this interaction in driving antioxidant capacity. The gene discussed is EP300; the disease is cancer.